Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Total Costs & Expenses

$11.56B

TTM · Period ending: Jun 30, 2026 · USD

REGN Total Costs & Expenses

Latest reported$11.56Bperiod endingJun 30, 2026

Latest reported$11.56Bperiod endingJun 30, 2026

REGN Total Costs & Expenses ($8.30M → $11.56B)

Annual Total Costs & Expenses

High-resolution chart · PNG

REGN total costs & expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Total Costs & Expenses — Annual fiscal periods (USD)
Period ending	Total Costs & Expenses (USD)
Dec 31, 2025	10,765,000,000
Dec 31, 2024	10,211,300,000
Dec 31, 2023	8,768,600,000
Dec 31, 2022	6,787,300,000
Dec 31, 2021	7,124,900,000
Dec 31, 2020	4,920,500,000
Dec 31, 2019	4,347,800,000
Dec 31, 2018	4,176,399,999
Dec 31, 2017	3,792,636,000
Dec 31, 2016	3,529,686,000
Dec 31, 2015	2,851,812,000
Dec 31, 2014	1,981,126,000
Dec 31, 2013	1,344,217,000
Dec 31, 2012	917,964,000
Dec 31, 2011	650,983,000
Dec 31, 2010	556,546,000
Dec 31, 2009	453,371,000
Dec 31, 2008	328,287,000
Dec 31, 2007	239,478,000
Dec 31, 2006	170,754,000
Dec 31, 2005	188,401,000
Dec 31, 2004	168,371,000
Dec 31, 2003	157,485,000
Dec 31, 2002	143,941,000
Dec 31, 2001	107,656,000
Dec 31, 2000	84,552,000
Dec 31, 1999	58,300,000
Dec 31, 1998	50,800,000
Dec 31, 1997	40,600,000
Dec 31, 1996	41,400,000
Dec 31, 1995	35,000,000
Dec 31, 1994	52,400,000
Dec 31, 1993	49,400,000
Dec 31, 1992	29,800,000
Dec 31, 1991	16,900,000
Dec 31, 1990	8,300,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.